Kevin O'Neill

Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.

Cambridge Display Technology ltd. develops display technologies based on polymer organic light emitting diodes (P-OLEDs). It primarily focuses on developing P-OLEDs for display and lighting applications, as well as organic semiconductor and photovoltaic applications. The firm specializes in the areas of materials development, device optimization and modeling, manufacturing processes, and intellectual property. The company was founded by Richard Friend, Jeremy Burroughes, and Donal Donat Conor Bradley on January 2, 1992 and is headquartered in Godmanchester, the United Kingdom.

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

Part of Sumitomo Chemical Co., Ltd., CDT Holdings Ltd. provides professional, scientific and technical services. The company is based in Godmanchester, UK.

Part of Sumitomo Chemical Co., Ltd., Sumika Chemical Analysis Service Ltd. was founded in 1972 and is a general analysis company based in Osaka, Japan. The Japanese company provides registration application services for chemical regulations and application support services necessary for manufacturing, selling, and exporting pharmaceuticals and medical equipment. The company strategically consults necessary exams during the registration process and offer evaluation and analysis of various raw materials and products, environmental surveys, risk management support, and consultancy services for research and development, application, manufacturing, and sales of pharmaceuticals.

BONAC Corp. develops diagnostic drugs based on nucleic acid chemistry. The company was founded in February 2010 and is headquartered in Kurume, Japan.

Sunovion Pharmaceuticals Europe Ltd. is a British European pharmaceutical company founded in 2013 that is dedicated to improving the lives of patients through the supply of essential medicines. The company is based in London, UK. The company commercializes and distributes a portfolio of specialty brands and hospital products in 40 countries worldwide, both directly and through strategic partnerships. The company's vision is to become a recognized partner of choice through their commercial excellence, patient focus, and presence across the globe. Sunovion Pharmaceuticals Europe aims to have a positive impact on society through their pioneering focus on their environment, social, and governance (ESG) goals.